Orlando, FL – September 22, 2024 – Neurology One is excited to announce its recent membership in the Parkinson’s Study Group (PSG) , the largest clinical research network dedicated solely to Parkinson’s Disease. This prestigious recognition highlights Neurology One’s unwavering commitment to advancing clinical research and delivering the best possible care for individuals affected by Parkinson’s in Central Florida.
A Significant Milestone in Parkinson’s Disease Research
Becoming a part of the Parkinson’s Study Group is a remarkable achievement for Neurology One, further solidifying its role as a leader in neurological care and research in the region. Dr. Ramon L. Rodriguez, MD, FAAN, and Medical Director at Neurology One, expressed his excitement about this significant accomplishment.
This milestone not only acknowledges the high standards of care Neurology One provides but also opens up new avenues for Parkinson’s patients in the region to access advanced clinical trials and novel treatment options.
What Is the Parkinson’s Study Group?
The Parkinson’s Study Group (PSG) is an internationally renowned network that collaborates with leading medical institutions across the globe to enhance Parkinson’s Disease research. PSG plays a pivotal role in advancing clinical research, contributing to the development of new therapies and improving patient outcomes.
By joining this esteemed network, Neurology One aims to make a significant impact on the research landscape and contribute to the global mission of finding better treatments and, ultimately, a cure for Parkinson’s Disease.
How This Benefits Parkinson’s Patients in Central Florida
For individuals living with Parkinson’s Disease, access to cutting-edge research and clinical trials is crucial in exploring new treatment options that may not yet be widely available. With Neurology One’s new membership in the Parkinson’s Study Group, patients in Orlando and Central Florida can now participate in innovative clinical trials, providing them with opportunities to receive advanced therapies and treatments that could improve their quality of life.
Neurology One has always prioritized patient care, providing personalized treatment plans and comprehensive support services. The addition of PSG membership will expand its capabilities in offering the latest in Parkinson’s research, providing its patients with unparalleled access to novel treatments.
Advancing Research, Enhancing Care
At Neurology One, research is at the core of its mission to improve the lives of those affected by neurological disorders. By joining the Parkinson’s Study Group, the clinic is poised to make significant strides in the advancement of Parkinson’s Disease treatments. This achievement reflects Neurology One’s dedication to pushing the boundaries of clinical research and offering its patients the most innovative and effective care available.
Contact Neurology One for More Information
Jennifer L. Morgera
Clinic Manager
Neurology One
Tel: 407-916-0304
Email: jmorgera@neurologyone.com
About Neurology One
Neurology One is a leading provider of neurological care in Central Florida, specializing in the treatment and management of a wide range of neurological conditions. With a team of expert physicians, nurse practitioners, and healthcare professionals, Neurology One is committed to delivering comprehensive, patient-centered care supported by innovative research. As an active participant in clinical trials and research initiatives, Neurology One is dedicated to advancing neurological health and improving patient outcomes.
